PLA2G2D expression level of CR/PR patients also showed a higher tendency compared with stable disease (SD) and progressive disease (PD) patients; however, these differences failed to reach statistical significance ( Figure 9B ).
← all excerpts
Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
1
—
—